Basket Study (CT-100-002) to Evaluate the Effects of a DiNaMo™ Component Training (NCT05573685) | Clinical Trial Compass
CompletedNot Applicable
Basket Study (CT-100-002) to Evaluate the Effects of a DiNaMo™ Component Training
United States124 participantsStarted 2022-10-10
Plain-language summary
CT-100 is a platform that provides interactive, software based therapeutic components that may be used as part of a multimodal treatment in supplementary or standalone prescription or nonprescription software-based digital therapeutics (PDT/DTx), being developed by Click Therapeutics, Inc. (Click).
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Meets indication-specific eligibility criteria as reported by the study participant with adequate clinical documentation
* Self-reported average pain intensity during the last 7 days of ≥ 3 of 10 on the Numeric rating Scale (NRS scale) associated with the primary indication
* Fluent in written and spoken English (confirmed by ability to read and comprehend the informed consent form.)
* Willing and able to comply with study protocol and assessments, evidenced by completion of the Screening Survey.
* Lives in the United States.
* Has an active email address and is willing and able to receive email messages.
* Is the sole user of an iPhone with iPhone operating systems (iOS) 14 or later capabilities or a smartphone with an Android operating system (OS) 10 or later capabilities with cellular and/or internet access for the duration of the study period.
Exclusion Criteria:
* Has a comorbid acute pain condition, such as from current injuries
* Participation in a clinical trial (including psychotherapy, mindfulness, cognitive training, or drug treatment) within the last 2 months
* Initiation or change in primary disease-specific medication for 30 days prior to entering the study
* Self-reported substance use disorder within the past 1 year
* Daily use of opioids of 30 MME (Morphine Milligram Equivalents) or more
* Substance use disorder within the past 1 year.
* Initiation or change in central nervous system-active medication (e.g., antidepressants) during th…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
To estimate the effect size for changes in pain experience (interference) in the Treatment App group compared to the Digital Control App group